1. DePhillipo NN, Aman ZS, Kennedy MI, Begley JP, Moatshe G, LaPrade RF. Efficacy of Vitamin C Supplementation on Collagen Synthesis and Oxidative Stress After Musculoskeletal Injuries: A Systematic Review. Orthop J Sport Med. 2018;6(10):2325967118804544. doi:10.1177/2325967118804544

  2. Waibel JS, Mi Q-S, Ozog D, et al. Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression. Lasers Surg Med. 2016;48(3):238-244. doi:10.1002/lsm.22448

  3. Jeong J-H, Kim M-B, Kim C, Hwang J-K. Inhibitory effect of vitamin C on intrinsic aging in human dermal fibroblasts and hairless mice. Food Sci Biotechnol. 2018;27(2):555-564. doi:10.1007/s10068-017-0252-6

  4. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11). doi:10.3390/nu9111211

  5. Su M, Guo C, Liu M, Liang X, Yang B. Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacology. Int Immunopharmacol. 2019;66:383-387. doi:10.1016/j.intimp.2018.11.048

  6. Elste V, Troesch B, Eggersdorfer M, Weber P. Emerging Evidence on Neutrophil Motility Supporting Its Usefulness to Define Vitamin C Intake Requirements. Nutrients. 2017;9(5). doi:10.3390/nu9050503

  7. Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15(1):26-34. doi:10.1097/HJR.0b013e3282f11f95

  8. Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr. 2004;80(6):1508-1520. doi:10.1093/ajcn/80.6.1508

  9. McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med. 2008;7(2):48-58. doi:10.1016/j.jcme.2008.01.002

  10. Rodrigues da Silva M, Schapochnik A, Peres Leal M, et al. Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat. PLoS One. 2018;13(11):e0205535. doi:10.1371/journal.pone.0205535

  11. Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane database Syst Rev. 2013;(1):CD000980. doi:10.1002/14651858.CD000980.pub4

  12. Mock DM. Biotin: From Nutrition to Therapeutics. J Nutr. 2017;147(8):1487-1492. doi:10.3945/jn.116.238956

  13. Xiang X, Liu Y, Zhang X, Zhang W, Wang Z. [Effects of biotin on blood glucose regulation in type 2 diabetes rat model]. Wei Sheng Yan Jiu. 2015;44(2):185-189,195.

  14. Lipner SR. Rethinking biotin therapy for hair, nail, and skin disorders. J Am Acad Dermatol. 2018;78(6):1236-1238. doi:10.1016/j.jaad.2018.02.018

  15. Lipner SR, Scher RK. Biotin for the treatment of nail disease: what is the evidence? J Dermatolog Treat. 2018;29(4):411-414. doi:10.1080/09546634.2017.1395799

  16. Spence JD. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr Res. 2016;36(2):109-116. doi:10.1016/j.nutres.2015.10.003

  17. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: a review. Int psychogeriatrics. 2012;24(4):541-556. doi:10.1017/S1041610211002511

  18. Leahy LG. Vitamin B Supplementation: What’s the Right Choice for Your Patients? J Psychosoc Nurs Ment Health Serv. 2017;55(7):7-11. doi:10.3928/02793695-20170619-02

  19. Koury MJ, Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004;24:105-131. doi:10.1146/annurev.nutr.24.012003.132306

  20. Bunn HF. Vitamin B12 and pernicious anemia--the dawn of molecular medicine. N Engl J Med. 2014;370(8):773-776. doi:10.1056/NEJMcibr1315544

  21. Tucker KL, Rich S, Rosenberg I, et al. Plasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring study. Am J Clin Nutr. 2000;71(2):514-522. doi:10.1093/ajcn/71.2.514

  22. Superko HR, Zhao X-Q, Hodis HN, Guyton JR. Niacin and heart disease prevention: Engraving its tombstone is a mistake. J Clin Lipidol. 2017;11(6):1309-1317. doi:10.1016/j.jacl.2017.08.005

  23. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231(4):360-381.

  24. Gehring W. Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol. 2004;3(2):88-93. doi:10.1111/j.1473-2130.2004.00115.x

  25. Lin F, Xu W, Guan C, et al. Niacin protects against UVB radiation-induced apoptosis in cultured human skin keratinocytes. Int J Mol Med. 2012;29(4):593-600. doi:10.3892/ijmm.2012.886

  26. Ulger B V, Kapan M, Uslukaya O, et al. Comparing the effects of nebivolol and dexpanthenol on wound healing: an experimental study. Int Wound J. 2016;13(3):367-371. doi:10.1111/iwj.12314

  27. Nitto T, Onodera K. Linkage between coenzyme a metabolism and inflammation: roles of pantetheinase. J Pharmacol Sci. 2013;123(1):1-8.

  28. Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. Nutrients. 2016;8(2):68. doi:10.3390/nu8020068

  29. Abraham GE, Schwartz UD, Lubran MM. Effect of vitamin B-6 on plasma and red blood cell magnesium levels in premenopausal women. Ann Clin Lab Sci. 1981;11(4):333-336.

  30. Mikawa Y, Mizobuchi S, Egi M, Morita K. Low serum concentrations of vitamin B6 and iron are related to panic attack and hyperventilation attack. Acta Med Okayama. 2013;67(2):99-104. doi:10.18926/AMO/49668

  31. Yasuda H, Fujiwara N, Ishizaki Y, Komatsu N. Anemia attributed to vitamin B6 deficiency in post-pancreaticoduodenectomy patients. Pancreatology. 2015;15(1):81-83. doi:10.1016/j.pan.2014.12.001

  32. Ashoori M, Saedisomeolia A. Riboflavin (vitamin B(2)) and oxidative stress: a review. Br J Nutr. 2014;111(11):1985-1991. doi:10.1017/S0007114514000178

  33. Thakur K, Tomar SK, Singh AK, Mandal S, Arora S. Riboflavin and health: A review of recent human research. Crit Rev Food Sci Nutr. 2017;57(17):3650-3660. doi:10.1080/10408398.2016.1145104

  34. Spector R. Riboflavin homeostasis in the central nervous system. J Neurochem. 1980;35(1):202-209.

  35. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1346-1353. doi:10.1212/WNL.0b013e3182535d0c

  36. Alvarez OM, Gilbreath RL. Effect of dietary thiamine on intermolecular collagen cross-linking during wound repair: a mechanical and biochemical assessment. J Trauma. 1982;22(1):20-24.

  37. Henderson GI, Dillon M, Schenker S. Effect of diet-induced thiamine deficiency on visceral DNA synthesis and tissue composition. Biochem Pharmacol. 1976;25(20):2275-2284.

  38. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid Based Complement Alternat Med. 2006;3(1):49-59. doi:10.1093/ecam/nek009

  39. Santulli G, Nakashima R, Yuan Q, Marks AR. Intracellular calcium release channels: an update. J Physiol. 2017;595(10):3041-3051. doi:10.1113/JP272781

  40. Contet C, Goulding SP, Kuljis DA, Barth AL. BK Channels in the Central Nervous System. Int Rev Neurobiol. 2016;128:281-342. doi:10.1016/bs.irn.2016.04.001

  41. Bristow SM, Gamble GD, Stewart A, Horne AM, Reid IR. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr. 2015;114(11):1868-1874. doi:10.1017/S0007114515003694

  42. Lopez-Serrano D, Solano F, Sanchez-Amat A. Involvement of a novel copper chaperone in tyrosinase activity and melanin synthesis in Marinomonas mediterranea. Microbiology. 2007;153(Pt 7):2241-2249. doi:10.1099/mic.0.2007/006833-0

  43. Collins JF, Prohaska JR, Knutson MD. Metabolic crossroads of iron and copper. Nutr Rev. 2010;68(3):133-147. doi:10.1111/j.1753-4887.2010.00271.x

  44. Opazo CM, Greenough MA, Bush AI. Copper: from neurotransmission to neuroproteostasis. Front Aging Neurosci. 2014;6:143. doi:10.3389/fnagi.2014.00143

  45. Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2011;13(11):843-847. doi:10.1111/j.1751-7176.2011.00538.x

  46. Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013;4(3):378S-83S. doi:10.3945/an.112.003483

  47. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3-i14. doi:10.1093/ndtplus/sfr163

  48. King DE, Mainous AG 3rd, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24(3):166-171.

  49. Leach RMJ, Muenster AM. Studies on the role of manganese in bone formation. I. Effect upon the mucopolysaccharide content of chick bone. J Nutr. 1962;78:51-56. doi:10.1093/jn/78.1.51

  50. Lee B, Pine M, Johnson L, Rettori V, Hiney JK, Dees W Les. Manganese acts centrally to activate reproductive hormone secretion and pubertal development in male rats. Reprod Toxicol. 2006;22(4):580-585. doi:10.1016/j.reprotox.2006.03.011

  51. Chen P, Bornhorst J, Aschner M. Manganese metabolism in humans. Front Biosci (Landmark Ed. 2018;23:1655-1679.

  52. Ventura M, Melo M, Carrilho F. Selenium and Thyroid Disease: From Pathophysiology to Treatment. Int J Endocrinol. 2017;2017:1297658. doi:10.1155/2017/1297658

  53. Barranco WT, Hudak PF, Eckhert CD. Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States). Cancer Causes Control. 2007;18(1):71-77. doi:10.1007/s10552-006-0077-8

  54. Sayehmiri K, Azami M, Mohammadi Y, Soleymani A, Tardeh Z. The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2018;19(6):1431-1437. doi:10.22034/APJCP.2018.19.6.1431

  55. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84(4):762-773. doi:10.1093/ajcn/84.4.762

  56. Shahar A, Patel K V, Semba RD, et al. Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed. Mov Disord. 2010;25(12):1909-1915. doi:10.1002/mds.23218

  57. Akbaraly TN, Hininger-Favier I, Carriere I, et al. Plasma selenium over time and cognitive decline in the elderly. Epidemiology. 2007;18(1):52-58. doi:10.1097/01.ede.0000248202.83695.4e

  58. Kogan S, Sood A, Garnick MS. Zinc and Wound Healing: A Review of Zinc Physiology and Clinical Applications. Wounds a Compend Clin Res Pract. 2017;29(4):102-106.

  59. Pisano M, Hilas O. Zinc and Taste Disturbances in Older Adults: A Review of the Literature. Consult Pharm. 2016;31(5):267-270. doi:10.4140/TCP.n.2016.267

  60. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001;20(2 Suppl):106-118.

  61. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2 Suppl):447S-463S. doi:10.1093/ajcn/68.2.447S

  62. Liu Y-L, Zhang M-N, Tong G-Y, et al. The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism. Asian J Androl. 2017;19(3):280-285. doi:10.4103/1008-682X.189621

  63. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344-348.

  64. Dissanayake D, Wijesinghe PS, Ratnasooriya WD, Wimalasena S. Effects of zinc supplementation on sexual behavior of male rats. J Hum Reprod Sci. 2009;2(2):57-61. doi:10.4103/0974-1208.57223

  65. Tan B, Li X, Yin Y, et al. Regulatory roles for L-arginine in reducing white adipose tissue. Front Biosci (Landmark Ed. 2012;17:2237-2246.

  66. Rutberg S. L-arginine may help blast belly fat. New Hope Network. Published 2014. Accessed January 8, 2019.

  67. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002-2012. doi:10.1056/NEJM199312303292706

  68. Jobgen W et al. Dietary l-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr. 2009;139(2):230-237.

  69. Norton LE, Layman DK. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J Nutr. 2006;136(2):533S-537S. doi:10.1093/jn/136.2.533S

  70. Blomstrand E, Eliasson J, Karlsson HKR, Kohnke R. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr. 2006;136(1 Suppl):269S-73S. doi:10.1093/jn/136.1.269S

  71. Jackman SR, Witard OC, Philp A, Wallis GA, Baar K, Tipton KD. Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans. Front Physiol. 2017;8:390. doi:10.3389/fphys.2017.00390

  72. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41(4 Suppl 4):S4-12.

  73. Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr. 2012;51(1):1-18. doi:10.1007/s00394-011-0284-2

  74. Smeland OB, Meisingset TW, Borges K, Sonnewald U. Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochem Int. 2012;61(1):100-107. doi:10.1016/j.neuint.2012.04.008

  75. DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O’Keefe JH. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc. 2013;88(6):544-551. doi:10.1016/j.mayocp.2013.02.007

  76. Sureda A, Cordova A, Ferrer MD, Perez G, Tur JA, Pons A. L-citrulline-malate influence over branched chain amino acid utilization during exercise. Eur J Appl Physiol. 2010;110(2):341-351. doi:10.1007/s00421-010-1509-4

  77. Moinard C, Nicolis I, Neveux N, Darquy S, Benazeth S, Cynober L. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr. 2008;99(4):855-862. doi:10.1017/S0007114507841110

  78. Takeda K, Machida M, Kohara A, Omi N, Takemasa T. Effects of citrulline supplementation on fatigue and exercise performance in mice. J Nutr Sci Vitaminol (Tokyo). 2011;57(3):246-250.

  79. Cormio L, De Siati M, Lorusso F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77(1):119-122. doi:10.1016/j.urology.2010.08.028

  80. Jepson MM, Bates PC, Broadbent P, Pell JM, Millward DJ. Relationship between glutamine concentration and protein synthesis in rat skeletal muscle. Am J Physiol. 1988;255(2 Pt 1):E166-72. doi:10.1152/ajpendo.1988.255.2.E166

  81. Calder PC, Yaqoob P. Glutamine and the immune system. Amino Acids. 1999;17(3):227-241.

  82. Kim M-H, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. Int J Mol Sci. 2017;18(5). doi:10.3390/ijms18051051

  83. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48(8):297-309.

  84. Civitelli R, Villareal DT, Agnusdei D, Nardi P, Avioli L V, Gennari C. Dietary L-lysine and calcium metabolism in humans. Nutrition. 1992;8(6):400-405.

  85. Dourmad JY, Noblet J, Etienne M. Effect of protein and lysine supply on performance, nitrogen balance, and body composition changes of sows during lactation. J Anim Sci. 1998;76(2):542-550.

  86. Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy. 1981;27(3):209-213. doi:10.1159/000237979

  87. Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica. 1987;175(4):183-190.

  88. Sugino T, Shirai T, Kajimoto Y, Kajimoto O. L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutr Res. 2008;28(11):738-743. doi:10.1016/j.nutres.2008.08.008

  89. Butterworth RF, Canbay A. Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease. Dig Dis. 2019;37(1):63-68. doi:10.1159/000491429

  90. Yan Z, Wang Y, Mao Q, et al. [Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase]. Zhonghua Gan Zang Bing Za Zhi. 2014;22(7):525-528. doi:10.3760/cma.j.issn.1007-3418.2014.07.010

  91. Le Boucher J, Eurengbiol, Farges MC, Minet R, Vasson MP, Cynober L. Modulation of immune response with ornithine A-ketoglutarate in burn injury: an arginine or glutamine dependency? Nutrition. 1999;15(10):773-777.

  92. Abdali D, Samson SE, Grover AK. How effective are antioxidant supplements in obesity and diabetes? Med Princ Pract. 2015;24(3):201-215. doi:10.1159/000375305

  93. Kucukgoncu S, Zhou E, Lucas KB, Tek C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obes Rev. 2017;18(5):594-601. doi:10.1111/obr.12528

  94. Shay K et al. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149-1160.

  95. Fava A, Pirritano D, Plastino M, et al. The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer’s Disease. J Neurodegener Dis. 2013;2013:454253. doi:10.1155/2013/454253

  96. Hager K, Kenklies M, McAfoose J, Engel J, Munch G. Alpha-lipoic acid as a new treatment option for Alzheimer’s disease--a 48 months follow-up analysis. J Neural Transm Suppl. 2007;(72):189-193.

  97. Shinto L, Quinn J, Montine T, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J Alzheimers Dis. 2014;38(1):111-120. doi:10.3233/JAD-130722

  98. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38(12):1425-1433.

  99. Xue R, Yang J, Wu J, Meng Q, Hao J. Coenzyme Q10 inhibits the activation of pancreatic stellate cells through PI3K/AKT/mTOR signaling pathway. Oncotarget. 2017;8(54):92300-92311. doi:10.18632/oncotarget.21247

  100. Hernandez-Camacho J et al. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;9:44.

  101. Cooke M, Iosia M, Buford T, et al. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr. 2008;5:8. doi:10.1186/1550-2783-5-8

  102. Coenzyme Q10. PDR Health. Accessed January 10, 2019.

  103. Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713-715. doi:10.1212/01.WNL.0000151975.03598.ED

  104. Gaucher C et al. Glutathione: Antioxidant properties dedicated to nanotechnologies. Antioxidants. 2018;7(5):62.

  105. Bains, VK & Bains R. The antioxidant master glutathione and periodontal health. Dent Res J. 2015;12(5):389-405.

  106. Sacco R, Eggenhoffner R, Giacomelli L. Glutathione in the treatment of liver diseases: insights from clinical practice. Minerva Gastroenterol Dietol. 2016;62(4):316-324.

  107. Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009;30(1-2):29-41. doi:10.1016/j.mam.2008.08.003

  108. Johnson, WM, Wilson-Delfosse, AL, & Mieyal J. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients. 2012;4(10):1399-1440.

  109. Kloek J, Mortaz E, van Ark I, Lilly CM, Nijkamp FP, Folkerts G. Glutathione prevents the early asthmatic reaction and airway hyperresponsiveness in guinea pigs. J Physiol Pharmacol. 2010;61(1):67-72.

  110. Balendiran, GK, Dabur, R, & Fraser D. The role of glutathione in cancer. Cell Biochem Funct. 2004;22(6):343-352.

  111. Lenton KJ, Sane AT, Therriault H, Cantin AM, Payette H, Wagner JR. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr. 2003;77(1):189-195. doi:10.1093/ajcn/77.1.189

  112. Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr. 1993;58(1):103-105. doi:10.1093/ajcn/58.1.103

  113. Taniguchi M, Nagao K, Inoue K, Imaizumi K. Cholesterol lowering effect of sulfur-containing amino acids added to a soybean protein diet in rats. J Nutr Sci Vitaminol (Tokyo). 2008;54(6):448-453.

  114. Thielemann LE, Oberhauser EW, Rosenblut G, Videla LA, Valenzuela A. Sulfur-containing amino acids that increase renal glutathione protect the kidney against papillary necrosis induced by 2-bromoethylamine. Cell Biochem Funct. 1990;8(1):19-24. doi:10.1002/cbf.290080104

  115. Ortmeyer HK. Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys. Obes Res. 1996;4(6):569-575.

  116. Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79(6):1290-1295. doi:10.1016/j.urology.2012.03.005

  117. Unfer V, Carlomagno G, Papaleo E, Vailati S, Candiani M, Baillargeon J-P. Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. Reprod Sci. 2014;21(7):854-858. doi:10.1177/1933719113518985

  118. Gelenberg AJ, Doller-Wojcik JC, Growdon JH. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry. 1979;136(6):772-776. doi:10.1176/ajp.136.6.772

  119. Cubells JM, Hernando C. Clinical trial on the use of cytidine diphosphate choline in Parkinson’s disease. Clin Ther. 1988;10(6):664-671.

  120. Bizzarri M, Carlomagno G. Inositol: history of an effective therapy for Polycystic Ovary Syndrome. Eur Rev Med Pharmacol Sci. 2014;18(13):1896-1903.

  121. Zacche MM, Caputo L, Filippis S, Zacche G, Dindelli M, Ferrari A. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(8):508-513. doi:10.1080/09513590903015544

  122. Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11(5):347-354.

  123. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2003;7(6):151-159.

  124. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem. 1988;263(6):2998-3004.

  125. Buchman AL, Dubin MD, Moukarzel AA, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22(5):1399-1403.

  126. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr. 2001;25(5):260-268. doi:10.1177/0148607101025005260

  127. Blusztajn JK, Slack BE, Mellott TJ. Neuroprotective Actions of Dietary Choline. Nutrients. 2017;9(8). doi:10.3390/nu9080815

  128. De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003;25(1):178-193.